经尿道柱状水囊前列腺扩开术治疗中年及高危患者良性前列腺增生

发布时间：2019-01-19 10:49

【摘要】：目的分析和总结采用经尿道柱状水囊前列腺扩开术治疗中年及高危前列腺增生患者的近期临床疗效和手术要点。方法回顾性分析2016年3-12月,该科收治的30例良性前列腺增生患者,其中9例为小于60岁中年患者,21例高危患者均大于80岁且有各种不同基础疾病,采用新手术方式经尿道柱状水囊前列腺扩开术治疗,按照手术标准流程进行。结果 30例患者均一次手术成功,均于前列腺12点方向扩开至脂肪层,手术时间短,出血量少,并发症发生率6.7%(2/30),术后拔除尿管均排尿通畅。术后随访1-6个月,国际前列腺症状评分(IPSS)、生活质量评分(QOL)、最大尿流率(Qmax)、残余尿(RUV)等各项指标与术前比较差异有统计学意义(P0.05)。结论经尿道柱状水囊前列腺扩开术治疗前列腺增生近期疗效确切,是治疗中年及高危患者良性前列腺增生的补充手术方式。
[Abstract]:Objective To analyze and summarize the recent clinical efficacy and surgical key points of the treatment of middle-aged and high-risk patients with benign prostatic hyperplasia by transurethral resection of the prostate. Methods From March to December, 2016, 30 cases of benign prostatic hyperplasia were treated by the Section, of which 9 were middle-aged patients with less than 60 years of age and 21 high-risk patients were more than 80 years old and have various basic diseases. Follow the procedure standard procedure. Results The operation was successful in 30 patients, and was spread to the fat layer in the 12-point direction of the prostate. The operation time was short, the amount of bleeding was low, and the complication rate was 60.7% (2/ 30). The postoperative follow-up was 1-6 months, the international prostate symptom score (IPSS), the quality of life (QOL), the maximum urinary flow rate (Qmax) and the residual urine (RUV) were statistically significant (P0.05). Conclusion The treatment of benign prostatic hyperplasia in the middle-aged and high-risk patients is the supplementary surgical method for the treatment of benign prostatic hyperplasia in middle-aged and high-risk patients.
【作者单位】：重庆医科大学附属第一医院泌尿外科;
【基金】：重庆市教委科技基金资助项目(KJ1500207)
【分类号】：R699.8

【相似文献】